Neil O'Connell

New open access paper in @TheJournal_Pain We make a Call to Action to the Pain Research community to make changes to enhance and ensure the trustworthiness of pain research sciencedirect.com/science/articl… . THREAD 1/16

Global Year Webinar: Towards Precision Medicine in Neuropathic Pain 1: Using Randomised Trial Evidence to Uncover Individual Treatment Effects ~ 19 March ~ bit.ly/4cmt68P

Episode 6 of Pain Exchange is out now! Listen to this episode to hear Andrew Rice, @LampertLabRWTH, and @NeilOConnell talk about this year’s Global Year campaign raising awareness about neuropathic pain. Listen anywhere you listen to podcasts! bit.ly/3JznbkG

19 March Global Year Webinar: Towards Precision Medicine in Neuropathic Pain 1: Using Randomised Trial Evidence to Uncover Individual Treatment Effects Register: bit.ly/4cmt68P

Register for the first 2026 Global Year webinar “Launching the IASP 2026 Global Year of Neuropathic Pain: What is Neuropathic Pain and Why Does it Matter?” on 29 Jan: bit.ly/3LkYSIa

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds. Read more here: cochrane.org/about-us/news/…

New: A critical appraisal tool for systematic reviews of prognostic factor studies 🔎 Prognostic factor research has increased across fields, with a subsequent increase in the number of systematic reviews of prognostic factors studies bmj.com/content/391/bm…?

Did you ask Santa for a critical appraisal tool for systematic reviews of prognostic factor studies? The new AMSTAR-PF tool is now published in @bmj_latest : lnkd.in/eFPz8SVP Excellent work from Michael Henry @UniversitySA driving this project. @cochranecollab

Massive congratulations to @mcferraro_ who had his PhD conferred this week. Michael was a superb PhD student, he finished his PhD with 12 first author publications (35 in total), and >$200K in funding. I'm looking forward to seeing how his research career develops.

Out today in @AnnalsofIM doi.org/10.7326/ANNALS… Our systematic review of 11 RCTs found bisphosphonates may reduce short-term pain but increase risk for AEs. Results limited by substantial, unexplained heterogeneity, introduced by inclusion of terminated trial data.

Nice summary of advances in pain research in 2025 just out in Lancet Neurology: thelancet.com/journals/laneu… Great to see ENTRUST-PE get a nod! entrust-pe.org

As an accompaniment to this new perspective piece on measuring harms in pain research, the recording of our webinar "Assessing harms in pain research" is now available. perc.iasp-pain.org/methodology-ev… @IASPpain @EFIC_org @BritishPainSoc

Our recent and excellent @IASP_MESISIG webinar "Optimising Openness and Transparency in Pain Research" is now free to view here perc.iasp-pain.org/methodology-ev…

To do no harm, we must first “know harms”. Our new perspective piece on the challenge of measuring and reporting adverse events in pain is now available in @PAINthejournal dx.doi.org/10.1097/j.pain… @mcferraro_ @aidancashin0 @EmmaFisher1 @IASP_MESISIG @IASPpain @EFIC_org

New systematic review focused on amputation for complex regional pain syndrome and briliantly led by @YannickGilanyifrom @UNSW and @PainIMPACTNeuRA , out now in@TheJournal_Pain sciencedirect.com/science/articl… HT @IASPpain @IASP_MESISIG @BritishPainSoc @EFIC_org @FacultyPainMed

🚨 BPS Endorses the ENTRUST-PE Framework The British Pain Society is proud to endorse ENTRUST-PE – a framework boosting the trustworthiness, transparency, and rigor of pain research. 🔗Read more: m.entrust-pe.org

Great to see the OPTIMETH framework for optimising clinical trials in CRPS and brilliantly led by @KeithMSmart, now out in @PainReportsOPEN journals.lww.com/painrpts/fullt… @IASPpain @EFIC_org @BritishPainSoc

Editorial commitment to trust and integrity in science: Implications for pain and anesthesiology research. academic.oup.com/painmedicine/a…